There was an interesting article in the Independent Online this morning about a recent trial study that has shown that the taking of methylenedioxymethamphetamine (ecstasy) could offer support for many people who are struggling with alcohol addiction: independent.co.uk/news/scie....
During an eight-week trial in Bristol, 14 people with alcohol problems were given a controlled amount of the party drug, also known as ecstasy, during two psychotherapy sessions. Psychological support was provided before, during and after each session and their alcohol use behaviour, mental wellbeing and functioning data were collected for nine months.
The study, published in the Journal of Psychopharmacology, found participants on average consumed 18.7 units of alcohol per week in the months after the trial, compared to 130.6 units before: journals.sagepub.com/eprint...
I think this is very much early days of this study. Although these findings do look promising, and any form of treatment that cuts down on the amount of damage being done to the liver can only be good news.
But, before everyone starts to get excited and begins to make plans to go out to some local rave once lockdown is lifted. It should be noted that early experiments on the effect of MDMA on rat livers do show that chronic administration of MDMA affects liver as well as lipoprotein profile in male rats. The exact mechanism of action needs further investigation.
So, swapping one set of treatments for another, might not prove so encouraging for those with liver fibrosis or cirrhosis.
Richard.